Navigation Links
Cell Biosciences Launches Next-Generation Protein Characterization System
Date:4/16/2009

PALO ALTO, Calif., April 16 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the launch of the Cell Biosciences CB1000 protein analysis system, a next-generation platform for ultrasensitive characterization of cell signaling proteins. The CB1000 establishes a new standard for sensitivity, reproducibility, and ease-of-use for researchers studying signaling pathways in limited samples, such as small tumor biopsies and stem cells. The CB1000 will be unveiled at the American Association for Cancer Research (AACR) 100th Annual Meeting, April 18-22, 2009, in Denver, Colorado (booth 2039).

The CB1000 system measures phosphorylation events and other protein post-translational modifications using capillary-based nanofluidic immunoassays, and builds upon the fundamental technology of its predecessor, the Firefly(TM) 3000 system. The advanced design of the CB1000 system provides significant improvements in assay performance and automation, including a doubling of sample throughput. Assay reproducibility and stability have been increased through the incorporation of precise temperature control systems. In addition, the CB1000's software package, Compass(TM), features dramatic improvements in data analysis speed.

David Hirschberg, Ph.D., Director of the Human Immune Monitoring Center at Stanford University School of Medicine, recently completed a three-month evaluation of a prototype CB1000 system. "This system represents an impressive step forward for Cell Biosciences' technology," noted Dr. Hirschberg. "My group has been using the CB1000 system heavily - typically six days a week. We have been extremely pleased by the system's high level of performance and reliability."

"The CB1000 is our first platform designed for broad distribution," added Tim Harkness, President and Chief Executive Officer at Cell Biosciences. "We believe that the CB1000 will allow us to penetrate important new markets as we build our worldwide commercial infrastructure. We also believe that the CB1000 will enable our customers to gain novel insights into the causes and treatment of human disease."

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. Our customers include leading institutions in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosciences is located in Palo Alto, California. For more information, visit www.cellbiosciences.com.


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Biosciences Announces Publication in Nature Medicine
2. Cell Biosciences Closes $10 Million Series C Financing
3. SAFC Biosciences(R) Expands Media Capability for Chinese Hamster Ovary (CHO) Cell Lines
4. SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free
5. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
6. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
7. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
8. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
9. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
10. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
11. Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Cancer diagnostics ... has joined its executive team to lead the development and commercialization of its ... help improve the diagnosis and treatment of cancer. The CIDT addresses the need ...
(Date:2/21/2017)... ... February 21, 2017 , ... Creation ... manufacturing solutions for original equipment manufacturers (OEMs) , today announced it has received ... third consecutive year winning in its category of electronics manufacturing services (EMS) providers ...
(Date:2/21/2017)... BANGALORE , February 21, 2017 ... Appropriate Technology for Adoption by Plastic Industry  ... STEER, ... and functionalise materials in the fields of plastics, pharmaceuticals, ... collaboration with Merck, a leading science & technology company, ...
(Date:2/20/2017)... BIOA ) announced today that Jean-Francois Huc has ... has been named President, effective immediately.  In his ... the construction, start-up and operation of the manufacturing plant in ...  Fabrice has also been extensively involved in the negotiations with CJ ... ...
Breaking Biology Technology:
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
Breaking Biology News(10 mins):